These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2265383)

  • 21. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
    He X; Johnston A
    Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
    Armenti VT; Radomski JS; Moritz MJ; Gaughan WJ; Philips LZ; McGrory CH; Coscia LA;
    Clin Transpl; 2002; ():121-30. PubMed ID: 12971441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
    Arranz R; Conde E; Rodriguez-Salvanés F; Pajuelo FJ; Cabrera R; Sanz MA; Petit J; Bueno J; Maldonado J; Odriozola J; Conde JG; Brunet S; Carreras E; Iriondo A; Fernández-Rañada JM; Marín P;
    Bone Marrow Transplant; 2002 Feb; 29(3):205-11. PubMed ID: 11859392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid-free immunosuppression in kidney transplant recipients: the University of Minnesota experience.
    Humar A; Dunn T; Kandaswamy R; Payne WD; Sutherland DE; Matas AJ
    Clin Transpl; 2007; ():43-50. PubMed ID: 18637457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreas transplantation in the United States (US) and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner A; Sutherland DE
    Clin Transpl; 1996; ():47-67. PubMed ID: 9286558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive regimens and their effects on renal allograft outcome.
    Katznelson S; Cecka JM
    Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-center multiple regression analysis of covariates associated with long-term cadaveric renal allograft survival: further improvement of long-term results with CsA.
    Peeters J; Christiaens MR; Coosemans W; Donck J; Roels L; Verberckmoes R; Waer M; Vanrenterghem Y
    Clin Transpl; 1995; ():255-60. PubMed ID: 8794271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998.
    Seikaly M; Ho PL; Emmett L; Tejani A
    Pediatr Transplant; 2001 Jun; 5(3):215-31. PubMed ID: 11422826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of immunosuppression in kidney transplantation: the Ohio State University experience.
    Rajab A; Pelletier RP; Henry ML; Elkhammas EA; Bumgardner GL; Davies EA; Orosz CG; Ferguson RM
    Clin Transpl; 2005; ():111-7. PubMed ID: 17424729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of immunosuppressive medications in solid organ transplantation.
    Schonder KS
    Crit Care Nurs Clin North Am; 2011 Sep; 23(3):405-23. PubMed ID: 22054818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Evolution of Lung Transplant Immunosuppression.
    Ivulich S; Westall G; Dooley M; Snell G
    Drugs; 2018 Jul; 78(10):965-982. PubMed ID: 29915895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of Immunosuppressive Therapy in Solid Organ Transplantation.
    Holt CD
    Anesthesiol Clin; 2017 Sep; 35(3):365-380. PubMed ID: 28784214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late graft loss after intestinal transplantation.
    Kaenkumchorn T; Wendel D; Pacheco MC; Horslen SP
    Curr Opin Organ Transplant; 2021 Apr; 26(2):220-228. PubMed ID: 33528223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive therapy and post-transplantation diarrhea.
    Pescovitz MD; Navarro MT
    Clin Transplant; 2001; 15 Suppl 4():23-8. PubMed ID: 11778784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles of immunosuppression.
    Chan GL; Gruber SA; Skjei KL; Canafax DM
    Crit Care Clin; 1990 Oct; 6(4):841-92. PubMed ID: 2265383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.